Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Andy Chen's Stock Ratings
Wolfe Research Analyst
Andy Chen is an analyst at Wolfe Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
34.7%
Smart Score
Overall Average Return Percentile
88th
Number of Ratings
50
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/24/2025 | ARGX | Buy Now | argenx | $844.00 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 11/12/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.09 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 11/06/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.30 | — | — | Initiates | → Peer Perform | Get Alert | |
| 10/10/2025 | AKRO | Buy Now | Akero Therapeutics | $54.70 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 09/19/2025 | ETNB | Buy Now | 89bio | — | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 08/04/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | — | — | Upgrade | Underperform → Peer Perform | Get Alert | |
| 08/04/2025 | VERA | Buy Now | Vera Therapeutics | $49.31 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 07/01/2025 | VRNA | Buy Now | Verona Pharma | — | — | → $170 | Initiates | → Outperform | Get Alert | |
| 06/17/2025 | BBIO | Buy Now | BridgeBio Pharma | $74.59 | -34.31% | → $49 | Initiates | → Outperform | Get Alert | |
| 06/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | — | — | Initiates | → Peer Perform | Get Alert | |
| 06/17/2025 | RNA | Buy Now | Avidity Biosciences | $71.86 | -23.46% | → $55 | Initiates | → Outperform | Get Alert | |
| 06/03/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 05/19/2025 | MLTX | Buy Now | MoonLake | $14.37 | 324.5% | → $61 | Upgrade | Peer Perform → Outperform | Get Alert | |
| 04/21/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.09 | 131.02% | → $21 | Upgrade | Peer Perform → Outperform | Get Alert | |
| 02/04/2025 | ANAB | Buy Now | AnaptysBio | $45.51 | — | — | Initiates | → Outperform | Get Alert | |
| 02/04/2025 | CRNX | Buy Now | Crinetics Pharmaceuticals | $50.99 | — | — | Initiates | → Peer Perform | Get Alert | |
| 02/04/2025 | ETNB | Buy Now | 89bio | — | — | — | Initiates | → Outperform | Get Alert | |
| 02/04/2025 | ORKA | Buy Now | Oruka Therapeutics | $30.10 | -33.55% | → $20 | Initiates | → Outperform | Get Alert | |
| 02/04/2025 | VERA | Buy Now | Vera Therapeutics | $49.31 | -0.63% | → $49 | Initiates | → Outperform | Get Alert | |
| 02/04/2025 | ZBIO | Buy Now | Zenas BioPharma | $32.60 | -41.72% | → $19 | Initiates | → Outperform | Get Alert | |
| 01/03/2025 | IMVT | Buy Now | Immunovant | $26.10 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 11/12/2024 | ARGX | Buy Now | argenx | $844.00 | -17.42% | → $697 | Upgrade | Peer Perform → Outperform | Get Alert | |
| 11/12/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | — | — | Downgrade | Peer Perform → Underperform | Get Alert | |
| 10/01/2024 | INCY | Buy Now | Incyte | $99.08 | — | — | Initiates | → Outperform | Get Alert | |
| 09/27/2024 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 09/25/2024 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | 88.26% | $51 → $51 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/26/2024 | MLTX | Buy Now | MoonLake | $14.37 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 08/26/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -24.14% | → $65 | Upgrade | Peer Perform → Outperform | Get Alert | |
| 06/11/2024 | AKRO | Buy Now | Akero Therapeutics | $54.70 | — | — | Initiates | → Outperform | Get Alert | |
| 06/11/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $555.55 | — | — | Initiates | → Outperform | Get Alert | |
| 06/11/2024 | VRDN | Buy Now | Viridian Therapeutics | $32.78 | — | — | Initiates | → Outperform | Get Alert | |
| 06/11/2024 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | — | — | Initiates | → Outperform | Get Alert | |
| 05/14/2024 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 04/11/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | — | Downgrade | Outperform → Peer Perform | Get Alert | |
| 04/10/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $80.20 | — | — | Upgrade | Peer Perform → Outperform | Get Alert | |
| 02/15/2024 | MLTX | Buy Now | MoonLake | $14.37 | — | — | Initiates | → Outperform | Get Alert | |
| 02/15/2024 | CRSP | Buy Now | CRISPR Therapeutics | $56.13 | — | — | Initiates | → Peer Perform | Get Alert | |
| 02/15/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | — | — | Initiates | → Peer Perform | Get Alert | |
| 02/15/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | — | — | Initiates | → Peer Perform | Get Alert | |
| 02/15/2024 | ROIV | Buy Now | Roivant Sciences | $21.89 | -22.34% | → $17 | Initiates | → Outperform | Get Alert | |
| 02/15/2024 | IMVT | Buy Now | Immunovant | $26.10 | 110.73% | → $55 | Initiates | → Outperform | Get Alert | |
| 02/15/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.09 | — | — | Initiates | → Peer Perform | Get Alert | |
| 02/15/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.00 | — | — | Initiates | → Outperform | Get Alert | |
| 02/15/2024 | ARGX | Buy Now | argenx | $844.00 | — | — | Initiates | → Peer Perform | Get Alert | |
| 02/15/2024 | INSM | Buy Now | Insmed | $197.01 | -78.68% | → $42 | Initiates | → Outperform | Get Alert | |
| 02/15/2024 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 29.96% | → $39 | Initiates | → Outperform | Get Alert | |
| 02/15/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | — | Initiates | → Outperform | Get Alert | |
| 10/18/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 09/14/2023 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 13.3% | → $34 | Initiates | → Buy | Get Alert | |
| 08/08/2023 | AFMD | Buy Now | Affimed | — | — | → $6 | Assumes | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved